Tag: Primary Mitochondrial Myopathy (PMM)

Stealth BioTherapeutics Completes Target Enrollment in Global Phase 3 NuPOWER Trial in Patients with Primary Mitochondrial Myopathy

Press Release / September 11, 2023August 25, 2026

MMPOWER Data Published in Neurology

Article / March 29, 2018April 14, 2025

2026
2025
2024
2023
2022
2019
2018
2016

References
Privacy Policy
Cookie Notice
Terms of Use
123 Highland Ave, Suite 201, Needham, MA 02494
Email Us

You are about to enter a third-party website that is not owned or controlled by Mighty Therapeutics. We are not responsible for the content, security, or privacy practices of any third-party website.